How Prediction Markets Could Distort Drug Approvals
Prediction markets, which aggregate public forecasts, may influence drug approval processes in ways that distort scientific evaluation. These markets could create biases by emphasizing popular opinion over rigorous clinical evidence, potentially affecting regulatory decisions and public health outcomes. The Bulletin of the Atomic Scientists highlights concerns about the impact of such markets on drug approval integrity.
Bulletin of the Atomic Scientists·


